Company Short-Term Debt: Korro Bio, Inc. (KRRO)

Symbol and logo of brand korrobio.com (KRRO)

Korro Bio, Inc. (KRRO) developments are currently in the pre-commercial stage, meaning the company operates on venture capital, as confirmed by the metric at 0.00. This price action chart on the GURU.Markets platform complements data on a business focused on creating RNA modification tools. Such an approach allows for the temporary alteration of gene function, helping to combat liver pathologies without interfering with the DNA structure.

KRRO Korro Bio, Inc. Company Short-Term Loans and Borrowings (02/21/2024 - 10/29/2026)

Analytical breakdowns and data insights for company Korro Bio Inc. (KRRO)

- current quotes and average value forecast:
Price Chart Korro Bio, Inc|KRRO - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value Korro Bio, Inc.|KRRO - Total Enterprise Value
- shareholders' equity book value data:
Net Assets per Single Share Korro Bio|KRRO - Accounting Value of Company|Market Value to Book Value Ratio korrobio.com|KRRO - Aggregate Asset Value
- debt and liquidity details:
Debt to Equity Korro Bio, Inc.|KRRO - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Korro Bio, Inc|KRRO - Aggregate Debt Obligations|Debts to Book Capitalization Korro Bio, Inc.|KRRO - Company Long-Term Debt|Company Short-Term Debts Korro Bio|Quick Liquidity korrobio.com
- earnings and multiples data:
KRRO - Company Net Income
General company analysis:korrobio.com (KRRO)
Mass-produced product of Korro Bio, Inc.

Investors assess the margin of safety for Korro Bio, Inc. (KRRO) through the balance of liquidity and liabilities. Outsourcing early-stage trials to external laboratories reduces capital expenditures, optimizing the operating cycle. The dynamics of short-term borrowings under one year reflect the volume of debt maturing within twelve months. A decrease in this metric confirms financial stability and independence from creditors. This asset is categorized as a high-risk biopharmaceutical company.

Competitor analysis for Korro Bio, Inc.

TEM - Company Short-Term Debt|QGEN - Company Short-Term Debts|Ionis Pharma (IONS) - Company Short-Term Debt|Short-Term Debt Repligen Inc. (RGEN)|Company Short-Term Debt Avidity Biosciences|CRSP: Company Short-Term Loans and Borrowings|Company Short-Term Debt GeneDx (WGS)|RARE (Ultragenyx Pharmaceutical Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Beam Therapeutics Corp BEAM|Sarepta Corp (SRPT) - Short-Term Debt|TWST: Company Current Liabilities|Company Short-Term Loans and Borrowings TXG (10xgenomics.com)|NTLA: Company Short-Term Debts|STOK (Stoke Therapeutics Inc) - Company Short-Term Debt|BLFS (BioLife Corp) - Company Short-Term Debts|Wave Pharma (WVE) - Short-Term Debt Volume|Company Short-Term Debt Maze Therapeutics Inc (MAZE)|SION - Short-Term Debt|Prime Medicine - Company Current Liabilities|Company Short-Term Loans and Borrowings TSHA|uniQure Corp - Company Short-Term Debts|Short-Term Debt Volume MeiraGTx Corp MGTX|REGENXBIO Inc. (RGNX) - Company Short-Term Debt|Company Short-Term Indebtedness SLDB|OCGN (Ocugen) - Company Short-Term Debts|Company Current Liabilities Pacific Biosciences of California, Inc. (PACB)|Company Current Liabilities BNTC (Benitec)|Short-Term Debt Volume Design Corp|Company Short-Term Debt Rocket Pharmaceuticals RCKT|Company Short-Term Debts 4dmoleculartherapeutics.com FDMT|LXEO - Company Short-Term Debt|Company Short-Term Loans and Borrowings EDIT (Editas Medicine Inc)|Silence Therapeutics Inc. (SLN) - Company Short-Term Debt|ProQR Therapeutics - Company Short-Term Loans and Borrowings|Company Short-Term Debt Codexis Inc|Short-Term Debt sangamo.com SGMO|Company Short-Term Debts NAUT|Metagenomi Inc. - Company Short-Term Indebtedness|Company Short-Term Debt Precision BioSciences DTIL|GBIO: Company Short-Term Indebtedness|Boundless Bio, Inc. - Company Short-Term Debts|XCUR - Company Short-Term Debts|imunon.com (IMNN) - Company Short-Term Debt|Phio Pharmaceuticals Corp. (PHIO) - Company Short-Term Debts|Company Short-Term Debt Mustang Bio Inc|Short-Term Debt TransCode RNAZ|Company Short-Term Debt Bionano Genomics, Inc. (BNGO)|APDN (adnas.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt bluebird bio BLUE|Company Short-Term Loans and Borrowings IPA|OMGA - Company Short-Term Debt|Short-Term Debt Singular Genomics Corp|RGLS (Regulus Therapeutics) - Company Current Liabilities|syros.com - Company Short-Term Loans and Borrowings|TBIO (Telesis Bio) - Company Short-Term Debts|Company Short-Term Debt TCON|Company Short-Term Debts UBX